Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 4
2014 4
2015 3
2016 13
2017 9
2018 12
2019 11
2020 11
2021 8
2022 22
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Incremental value of serum neurofilament light chain and glial fibrillary acidic protein as blood-based biomarkers for predicting functional outcome in severe acute ischemic stroke.
Vollmuth C, Fiessler C, Montellano FA, Kollikowski AM, Essig F, Oeckl P, Barba L, Steinacker P, Schulz C, Ungethüm K, Wolf J, Pham M, Schuhmann MK, Heuschmann PU, Haeusler KG, Stoll G, Otto M, Neugebauer H. Vollmuth C, et al. Among authors: oeckl p. Eur Stroke J. 2024 Feb 24:23969873241234436. doi: 10.1177/23969873241234436. Online ahead of print. Eur Stroke J. 2024. PMID: 38400734 Free article.
Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assays.
Fazeli B, Gómez de San José N, Jesse S, Senel M, Oeckl P, Erhart DK, Ludolph AC, Otto M, Halbgebauer S, Tumani H. Fazeli B, et al. Among authors: oeckl p. Clin Chem Lab Med. 2024 Feb 7. doi: 10.1515/cclm-2023-1256. Online ahead of print. Clin Chem Lab Med. 2024. PMID: 38353147 Free article.
Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.
Barba L, Vollmuth C, Abu-Rumeileh S, Halbgebauer S, Oeckl P, Steinacker P, Kollikowski AM, Schultz C, Wolf J, Pham M, Schuhmann MK, Heuschmann PU, Haeusler KG, Stoll G, Neugebauer H, Otto M. Barba L, et al. Among authors: oeckl p. Sci Rep. 2023 Nov 28;13(1):20941. doi: 10.1038/s41598-023-47765-7. Sci Rep. 2023. PMID: 38017278 Free PMC article.
Plasma β-synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy.
Abu-Rumeileh S, Barba L, Bache M, Halbgebauer S, Oeckl P, Steinacker P, Güttler A, Keßler J, Illert J, Strauss C, Vordermark D, Otto M. Abu-Rumeileh S, et al. Among authors: oeckl p. Ann Clin Transl Neurol. 2023 Oct;10(10):1924-1930. doi: 10.1002/acn3.51878. Epub 2023 Aug 23. Ann Clin Transl Neurol. 2023. PMID: 37608748 Free PMC article.
High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt-Jakob disease.
Abu-Rumeileh S, Halbgebauer S, Bentivenga GM, Barba L, Baiardi S, Mastrangelo A, Oeckl P, Steinacker P, Mammana A, Capellari S, Otto M, Parchi P. Abu-Rumeileh S, et al. Among authors: oeckl p. Ann Clin Transl Neurol. 2023 Oct;10(10):1904-1909. doi: 10.1002/acn3.51873. Epub 2023 Aug 8. Ann Clin Transl Neurol. 2023. PMID: 37553789 Free PMC article.
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease.
Barba L, Abu-Rumeileh S, Halbgebauer S, Bellomo G, Paolini Paoletti F, Gaetani L, Oeckl P, Steinacker P, Massa F, Parnetti L, Otto M. Barba L, et al. Among authors: oeckl p. Neurology. 2023 Jul 4;101(1):e50-e62. doi: 10.1212/WNL.0000000000207371. Epub 2023 May 15. Neurology. 2023. PMID: 37188538
Blood β-synuclein is related to amyloid PET positivity in memory clinic patients.
Oeckl P, Bluma M, Bucci M, Halbgebauer S, Chiotis K, Sandebring-Matton A, Ashton NJ, Molfetta GD, Grötschel L, Kivipelto M, Blennow K, Zetterberg H, Savitcheva I, Nordberg A, Otto M. Oeckl P, et al. Alzheimers Dement. 2023 Nov;19(11):4896-4907. doi: 10.1002/alz.13046. Epub 2023 Apr 13. Alzheimers Dement. 2023. PMID: 37052206
Trial of Deferiprone in Parkinson's Disease.
Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon Delannoy P, Poewe W, Compta Y, Pavese N, Růžička E, Dušek P, Post B, Bloem BR, Berg D, Maetzler W, Otto M, Habert MO, Lehericy S, Ferreira J, Dodel R, Tranchant C, Eusebio A, Thobois S, Marques AR, Meissner WG, Ory-Magne F, Walter U, de Bie RMA, Gago M, Vilas D, Kulisevsky J, Januario C, Coelho MVS, Behnke S, Worth P, Seppi K, Ouk T, Potey C, Leclercq C, Viard R, Kuchcinski G, Lopes R, Pruvo JP, Pigny P, Garçon G, Simonin O, Carpentier J, Rolland AS, Nyholm D, Scherfler C, Mangin JF, Chupin M, Bordet R, Dexter DT, Fradette C, Spino M, Tricta F, Ayton S, Bush AI, Devedjian JC, Duce JA, Cabantchik I, Defebvre L, Deplanque D, Moreau C; FAIRPARK-II Study Group. Devos D, et al. N Engl J Med. 2022 Dec 1;387(22):2045-2055. doi: 10.1056/NEJMoa2209254. N Engl J Med. 2022. PMID: 36449420 Clinical Trial.
91 results